NCT01869218View on ClinicalTrials.gov

Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 2, 2013

Primary Completion Date

August 3, 2015

Study Completion Date

January 15, 2021

Conditions
Hematologic Neoplasms
Trial Locations (1)

80045

University of Colorado Cancer Center, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT01869218 - Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy | Biotech Hunter | Biotech Hunter